Howard Univ. Washington DC NICHD CRS — Washington D.C., District of Columbia

Howard Univ. Washington DC NICHD CRS is a clinical research site located in Washington D.C., District of Columbia, United States 20060.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Howard Univ. Washington DC NICHD CRS has participated in 28 clinical trials.

Therapeutic areas: HIV Infections, Sexually Transmitted Diseases, H1N1 Influenza Virus.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Howard Univ. Washington DC NICHD CRS?

Howard Univ. Washington DC NICHD CRS has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Howard Univ. Washington DC NICHD CRS conducted?

Howard Univ. Washington DC NICHD CRS has 28 clinical trials on record. Their work covers HIV Infections, Sexually Transmitted Diseases, H1N1 Influenza Virus.

Is Howard Univ. Washington DC NICHD CRS accredited by Crixeo Health?

Yes — Howard Univ. Washington DC NICHD CRS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Howard Univ. Washington DC NICHD CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.